Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Bio-Techne Corp. (TECH) PT Raised to $560 at Stifel
August 5, 2021 3:56 PM EDTStifel analyst Daniel Arias raised the price target on Bio-Techne Corp. (NASDAQ: TECH) to $560.00 (from $475.00) while maintaining a Buy rating.
The analyst commented, "Bio-Techne posted another strong quarter on the heels of the lab spending rebound and demand for a portfolio that... More
Bio-Techne (TECH) Tops Q4 EPS by 17c
August 5, 2021 6:52 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.87, $0.17 better than the analyst estimate of $1.70. Revenue for the quarter came in at $259 million versus the consensus estimate of $244.62 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More